Subsequent Vaccination Cuts Risk for COVID-19 Reinfection
Vaccine effectiveness estimated at 82 percent for those aged 16 to 64 years, 60 percent for those aged 65 years or older
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.